Combined Stereotactic Body Radiotherapy and Checkpoint Inhibition in Unresectable Hepatocellular Carcinoma: A Potential Synergistic Treatment Strategy

Background: Current treatments of unresectable hepatocellular carcinoma (HCC) are trans-arterial chemo-embolization (TACE), stereotactic body radiotherapy (SBRT), and targeted therapy. However, these treatments are limited in efficacy and safety for patients with large tumor sizes. Here, we report a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Chi-Leung, Chan, Albert C. Y., Chiu, Keith W. H., Kong, Feng-Ming (Spring)
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874138/
https://www.ncbi.nlm.nih.gov/pubmed/31799176
http://dx.doi.org/10.3389/fonc.2019.01157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874138/
https://www.ncbi.nlm.nih.gov/pubmed/31799176
http://dx.doi.org/10.3389/fonc.2019.01157

Ejemplares similares